Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 11/20 | 0.68 |
| ▸ | CA1 | P00915 | 11/20 | 0.68 |
| ▸ | CA9 | Q16790 | 11/20 | 0.68 |
| ▸ | CA7 | P43166 | 6/20 | 0.68 |
| ▸ | CA6 | P23280 | 5/20 | 0.68 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.68 |
| ▸ | CA4 | P22748 | 5/20 | 0.68 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.68 |
| ▸ | CA5A | P35218 | 3/20 | 0.68 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.68 |
| ▸ | MTNR1A | P48039 | 4/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.67 |
| ▸ | MAOB | P27338 | 3/20 | 0.67 |
| ▸ | CA2 | P00918 | 3/20 | 0.65 |
| ▸ | CA3 | P07451 | 3/20 | 0.65 |
| ▸ | MAOA | P21397 | 2/20 | 0.60 |
| ▸ | HPGD | P15428 | 3/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| (E)-7-(2-Butenyloxy)Coumarin SCHEMBL12189889 | 0.87 | CA12 (0.69) | CA12CA1CA9CA7CA6 | |
| (E)-7-(2-Butenyloxy)Coumarin SCHEMBL18284641 | 0.87 | CA12 (0.69) | CA12CA1CA9CA7CA6 | |
| SCHEMBL12189878 | 0.86 | CA12 (0.68) | CA12CA1CA9CA7CA6 | |
| SCHEMBL12189886 | 0.86 | CA12 (0.68) | CA12CA1CA9CA7CA6 | |
| SCHEMBL4390495 | 0.82 | CA12 (0.75) | CA12CA1CA9CA7CA6 | |
| Ethoxycoumarin SCHEMBL119072 | 0.82 | CA9 (1.00) | CA12CA1CA9CA7CA6 | |
| 7-Allyloxycoumarin SCHEMBL4765530 | 0.81 | CA12 (1.00) | CA12CA1CA9CA7CA6 | |
| 7-Prenyloxycoumarin SCHEMBL4898255 | 0.80 | KDM4E (1.00) | CA12CA1CA9CA7CA6 | |
| SCHEMBL18292781 | 0.80 | MTNR1A (0.67) | CA12CA1CA9CA7CA6 | |
| 7-Butoxycoumarin SCHEMBL6686295 | 0.79 | CA12 (1.00) | CA12CA1CA9CA7CA6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8030466-B2 | 3′-o-fluorescently modified nucleotides and uses thereof | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2011-10-04 | — | — | US | disclosed |
| US-20110076679-A1 | 3'-O-FLUORESCENTLY MODIFIED NUCLEOTIDES AND USES THEREOF | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2011-03-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110076679-A1 | 3'-O-FLUORESCENTLY MODIFIED NUCLEOTIDES AND USES THEREOF | NUDT1, RNGTT, DNTT | CA12 4871/4885CA1 4851/4885CA9 4660/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.